Sanofi Fails To Shake Eisai's Lovenox Antitrust Suit
Sanofi-Aventis US LLC has lost its bid to nix Eisai Inc.'s antitrust suit accusing the pharmaceutical giant of drafting sales contracts for the anti-coagulant drug Lovenox that allow it to maintain...To view the full article, register now.
Already a subscriber? Click here to view full article